Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Despite numerous medication and lifestyle treatment options, just over half of patients with type 2 diabetes mellitus (T2DM) achieve a glycated haemoglobin (HbA1c) of <7%.1 Roux-en-y gastric bypass surgery (RYGB) has traditionally been reserved for treating severe obesity, but there is growing interest in using this and other bariatric procedures to treat T2DM in less obese patients.2 ,3 There have been few rigorous studies comparing RYGB against best available non-surgical treatment for control of T2DM and comorbid conditions.
Ikramuddin and colleagues conducted a …
Competing interests None.